United States · Health Care · USD (Thousands) · Annual
Key financials
USD|Thousands
ROE
58.89%
2026 (actual)
ROA
38.24%
2026 (actual)
Gross Margin
50.4%
2026 (actual)
Net Margin
30.14%
2026 (actual)
Total Assets
$138,289.84K
2026 (actual)
Net Income
$44,872.69K
2026 (actual)
Valuation
$387,769.12K
2026 (actual)
Stock Price
$0.36
Historical & projected performance
USD|Thousands
Reported figures and Equlion model projections for the next 5 years.
ROE
-44.5 pt
Company
Sector average
ROA
-25.7 pt
Company
Gross Margin
-18.2 pt
Company
Sector average
Net Margin
-14.9 pt
Company
Total Assets
+200.3%
Company
Sector average (own scale)
Net Income
+9.2%
Company
Valuation
+29.6%
Company
Sector average (own scale)
Stock Price
+30.6%
Company
Amounts in USD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2026. Projections are model estimates, not investment advice.
Want the full financial forecast report for ELITE PHARMACEUTICALS INC /NV/? It covers the balance sheet, income statement, cash flow and Equlion model projections.